Palisade BioPALI
13F holders, Q2 2024 (June 30)8holders
$4.52avg. 13F price*
At the end of Q2 2024, 8 institutions reported holding Palisade Bio Inc. (PALI) in their 13F filings. The largest holders were Marex Group Ltd ($162K), Armistice Capital, LLC ($125K) and UBS Group AG ($5K).
- Company
- Palisade Bio Inc.
- CUSIP
- 696389402
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 0 | $0 |
Ownership 8 holders
| Marex Group Ltd | 0.00% | Add +1400.0% | 35,759 | $162K |
| Armistice Capital, LLC | 0.00% | Reduce -42.0% | 27,858 | $125K |
| UBS Group AG | 0.00% | Add +719.8% | 1,216 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 738 | $3K |
| Morgan Stanley | 0.00% | Reduce -0.4% | 140 | $630 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 100 | $450 |
| Wells Fargo & Company | 0.00% | Reduce -23.4% | 21 | $95 |
| Bank of America Corp. | 0.00% | New | 5 | $22 |
"% of holder's portfolio" is PALI's weight in each manager's 13F, not the share of Palisade Bio Inc. the manager owns.